Royal London Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-23,978
| Closed | -$2.56M | – | 652 |
|
2024
Q2 | $2.56M | Buy |
23,978
+1,215
| +5% | +$130K | 0.01% | 606 |
|
2024
Q1 | $2.74M | Sell |
22,763
-471
| -2% | -$56.7K | 0.01% | 610 |
|
2023
Q4 | $2.86M | Sell |
23,234
-40
| -0.2% | -$4.92K | 0.01% | 606 |
|
2023
Q3 | $3.01M | Buy |
23,274
+2,049
| +10% | +$265K | 0.01% | 599 |
|
2023
Q2 | $2.63M | Buy |
21,225
+1,807
| +9% | +$224K | 0.01% | 601 |
|
2023
Q1 | $2.84M | Buy |
19,418
+2,033
| +12% | +$297K | 0.01% | 576 |
|
2022
Q4 | $2.77M | Sell |
17,385
-402
| -2% | -$64K | 0.01% | 578 |
|
2022
Q3 | $2.37M | Sell |
17,787
-3,448
| -16% | -$459K | 0.01% | 577 |
|
2022
Q2 | $3.31M | Buy |
21,235
+116
| +0.5% | +$18.1K | 0.02% | 544 |
|
2022
Q1 | $3.29M | Buy |
21,119
+884
| +4% | +$138K | 0.01% | 584 |
|
2021
Q4 | $2.58M | Buy |
20,235
+2,099
| +12% | +$268K | 0.01% | 598 |
|
2021
Q3 | $2.36M | Buy |
18,136
+783
| +5% | +$102K | 0.01% | 612 |
|
2021
Q2 | $3.08M | Hold |
17,353
| – | – | 0.01% | 604 |
|
2021
Q1 | $2.85M | Hold |
17,353
| – | – | 0.01% | 599 |
|
2020
Q4 | $2.87M | Sell |
17,353
-4,345
| -20% | -$717K | 0.02% | 551 |
|
2020
Q3 | $3.03M | Hold |
21,698
| – | – | 0.02% | 505 |
|
2020
Q2 | $2.38M | Sell |
21,698
-3,133
| -13% | -$343K | 0.02% | 526 |
|
2020
Q1 | $2.48M | Hold |
24,831
| – | – | 0.02% | 504 |
|
2019
Q4 | $3.69M | Hold |
24,831
| – | – | 0.03% | 494 |
|
2019
Q3 | $3.18M | Buy |
+24,831
| New | +$3.18M | 0.02% | 517 |
|
2019
Q2 | – | Sell |
-22,667
| Closed | -$3.24M | – | 613 |
|
2019
Q1 | $3.24M | Sell |
22,667
-2,894
| -11% | -$414K | 0.03% | 526 |
|
2018
Q4 | $3.11M | Sell |
25,561
-31,011
| -55% | -$3.77M | 0.03% | 519 |
|
2018
Q3 | $5.49M | Buy |
56,572
+30,897
| +120% | +$3M | 0.06% | 323 |
|
2018
Q2 | $4.42M | Buy |
+25,675
| New | +$4.42M | 0.04% | 416 |
|